SCHEMBL2907355

SCHEMBL2907355

CC(=O)OCC(=O)Oc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
CYP19A1 P11511 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.47
ELANE P08246 2/20 0.47
KMT2A Q03164 2/20 0.45
GAA P10253 2/20 0.44
MAPT P10636 2/20 0.44
HSP90AA1 P07900 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44
ALOX15 P16050 1/20 0.44
HPGD P15428 2/20 0.43
LMNA P02545 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
MEN1 O00255 1/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8069884 0.86 LMNA (0.55) ALDH1A1SMN1; SMN2ELANEKMT2AGAA
SCHEMBL28050810 0.84 HSD17B10 (0.59) ALDH1A1SMN1; SMN2ELANEKMT2AGAA
SCHEMBL8069859 0.83 LMNA (0.62) ALDH1A1SMN1; SMN2KMT2AGAAMAPT
SCHEMBL8068275 0.83 LMNA (0.44) ALDH1A1SMN1; SMN2ELANEKMT2AGAA
SCHEMBL15726613 0.82 PRSS1 (0.49) ALDH1A1CYP19A1ELANEKMT2AGAA
SCHEMBL10234471 0.82 ELANE (0.51) ALDH1A1CYP19A1ELANEKMT2AGAA
SCHEMBL7799861 0.81 KMT2A (0.50) ALDH1A1CYP19A1ELANEKMT2AGAA
SCHEMBL28238266 0.81 ELANE (0.51) ALDH1A1CYP19A1SMN1; SMN2ELANEKMT2A
SCHEMBL28116071 0.81 LMNA (0.43) ALDH1A1CYP19A1SMN1; SMN2KMT2AGAA
SCHEMBL8069813 0.81 KMT2A (0.50) ALDH1A1SMN1; SMN2ELANEKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7452545-B2 Oligosaccharide aldonic acids and their topical use YU RUEY J 2008-11-18 US claimed
US-20080090772-A1 Oligosaccharide Aldonic Acids and Their Topical Use YU RUEY J 2008-04-17 US claimed
EP-1685843-A1 Oligosaccharide aldonic acids and their topical use Yu, Ruey J., Dr. (US) 2006-08-02 EP claimed
EP-1227820-B1 OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE YU RUEY J (US) 2006-04-19 EP claimed
US-20040180854-A1 Oligosaccharide aldonic acids and their topical use YU RUEY J (US) 2004-09-16 US claimed
US-6740327-B2 USE FOR COSMETIC AND DERMATOLOGICAL INDICATIONS, REDUCING AND SOOTHING MUCOSA AND SKIN ERYTHEMA, INFLAMMATION OR REACTION CAUSED BY INTERNAL OR EXTERNAL FACTORS, WOUND HEALING, ETC. YU RUEY J (US) 2004-05-25 US claimed
EP-1227820-A2 OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE Yu, Ruey J., Dr. (US) 2002-08-07 EP claimed
US-20020028227-A1 Oligosaccharide aldonic acids and their topical use YU RUEY J (US) 2002-03-07 US claimed
US-6335023-B1 VEHICLES AND OLIGOSACCHARIDE ALDONIC ACIDS YU RUEY J (US) 2002-01-01 US claimed
WO-2001001932-A2 OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE YU RUEY J (US) 2001-01-11 WO claimed
US-6054479-A FOR FOOD, COSMETICS, DRUGS; ADDING ARYL ACETOXYACETIC ACID TRISTRATA, INC. (A DELAWARE CORPORATION) (US) 2000-04-25 US claimed
US-6046238-A TOPICALLY APPLYING TO AN AFFECTED AREA OF SKIN AN EFFECTIVE AMOUNT OF ARYL 2-ACETOXYETHANOIC ACID, EFFECTIVE TO REMOVE OR PREVENT THE SPREAD OF ACNE VULGARIS TRISTRATA, INC. (US) 2000-04-04 US claimed
US-5958975-A REVERSING OR PREVENTING TACHYPHYLAXIS OF PSORIASIS TO A CORTICOSTEROID; APPLYING TO PSORIATIC SKIN A CORTICOSTEROID AND AN ARYL 2-ACETOXY-ETHANOIC ACID; COSMETICS; FOODS TRISTRATA, INC. (US) 1999-09-28 US claimed
US-5874071-A USING AN ARYL 2-ACETOXYETHANOIC ACID; DEODERANTS; ANTIPRESPIRANTS; PREVENTION OF ODORS ASSOCIATED WITH FOOT, SCALP, SKIN, NAILS AND FOLLICULR INFECTIONS; PROPIONIBACTERIUM ACNES; FOODS; COSMETICS; DRUGS TRISTRATA, INC. (US) 1999-02-23 US claimed
US-5807890-A USING ARYL 2-ACETOXYETHANOIC ACID TRISTRATA, INC. (US) 1998-09-15 US claimed
EP-0789553-A4 ANTIODOR, ANTIMICROBIAL AND PRESERVATIVE COMPOSITIONS AND METHODS OF USING SAME TRISTRATA INC (US) 1998-05-06 EP claimed
EP-0789553-A1 ANTIODOR, ANTIMICROBIAL AND PRESERVATIVE COMPOSITIONS AND METHODS OF USING SAME Tristrata, Inc. (US) 1997-08-20 EP claimed
US-5641475-A INCLUDES ARYL 2-ACETOXYETHANOIC ACID AS SYNERGIST OR AMPLIFIER TRISTRATA, INC. (US) 1997-06-24 US claimed
WO-1996013247-A1 ANTIODOR, ANTIMICROBIAL AND PRESERVATIVE COMPOSITIONS AND METHODS OF USING SAME TRISTRATA, INC. (US) 1996-05-09 WO claimed
CN-111057494-A Preparation method of adhesive material for bamboo floor 南京旭华圣洛迪新型建材有限公司 2020-04-24 CN disclosed
WO-2020069353-A1 COMPOUNDS AND COMPOSITIONS FOR OCULAR DELIVERY Graybug Vision, Inc. (US) 2020-04-02 WO disclosed
US-9295634-B2 Topical with static photobiological functionality Maple Ridge Group, LLC (US) 2016-03-29 US disclosed
US-20140271503-A1 Topical With Static Photobiological Functionality Maple Ridge Group, LLC (US) 2014-09-18 US disclosed
CN-102260657-B Lipase gene and recombinase thereof, and application of lipase gene in preparing optically active mandelic acid UNIV EAST CHINA SCIENCE & TECH 2013-02-20 CN disclosed
WO-2011158257-A1 PREPARATION PROCESS OF FESOTERODINE AND INTERMEDIATES PANACEA BIOTEC LTD (IN) 2011-12-22 WO disclosed
CN-102260657-A Lipase gene and recombinase thereof, and application of lipase gene in preparing optically active mandelic acid 2011-11-30 CN disclosed
CN-101538542-B Pseudomonad esterase and application in preparing optical pure mandel and derivative thereof UNIV EAST CHINA SCIENCE & TECH 2010-12-29 CN disclosed
EP-2217725-A2 DIAGNOSTICS FOR AGING-RELATED DERMATOLOGIC DISORDERS Interleukin Genetics, Inc. (US) 2010-08-18 EP disclosed
CN-101538542-A Pseudomonad esterase and application in preparing optical pure mandel and derivative thereof UNIV EAST CHINA SCIENCE & TECH 2009-09-23 CN disclosed
WO-2009061506-A9 DIAGNOSTICS FOR AGING-RELATED DERMATOLOGIC DISORDERS INTERLEUKIN GENETICS, INC. (US) 2009-09-11 WO disclosed
US-20090170105-A1 Diagnostics for Aging-Related Dermatologic Disorders INTERLEUKIN GENETICS, INC. (US) 2009-07-02 US disclosed
WO-2009061506-A2 DIAGNOSTICS FOR AGING-RELATED DERMATOLOGIC DISORDERS INTERLEUKIN GENETICS, INC. (US) 2009-05-14 WO disclosed
US-6054479-A FOR FOOD, COSMETICS, DRUGS; ADDING ARYL ACETOXYACETIC ACID TRISTRATA, INC. (A DELAWARE CORPORATION) (US) 2000-04-25 US disclosed
US-6046238-A TOPICALLY APPLYING TO AN AFFECTED AREA OF SKIN AN EFFECTIVE AMOUNT OF ARYL 2-ACETOXYETHANOIC ACID, EFFECTIVE TO REMOVE OR PREVENT THE SPREAD OF ACNE VULGARIS TRISTRATA, INC. (US) 2000-04-04 US disclosed
US-5958975-A REVERSING OR PREVENTING TACHYPHYLAXIS OF PSORIASIS TO A CORTICOSTEROID; APPLYING TO PSORIATIC SKIN A CORTICOSTEROID AND AN ARYL 2-ACETOXY-ETHANOIC ACID; COSMETICS; FOODS TRISTRATA, INC. (US) 1999-09-28 US disclosed
US-5874071-A USING AN ARYL 2-ACETOXYETHANOIC ACID; DEODERANTS; ANTIPRESPIRANTS; PREVENTION OF ODORS ASSOCIATED WITH FOOT, SCALP, SKIN, NAILS AND FOLLICULR INFECTIONS; PROPIONIBACTERIUM ACNES; FOODS; COSMETICS; DRUGS TRISTRATA, INC. (US) 1999-02-23 US disclosed
US-5807890-A USING ARYL 2-ACETOXYETHANOIC ACID TRISTRATA, INC. (US) 1998-09-15 US disclosed
EP-0789553-A4 ANTIODOR, ANTIMICROBIAL AND PRESERVATIVE COMPOSITIONS AND METHODS OF USING SAME TRISTRATA INC (US) 1998-05-06 EP disclosed
EP-0789553-A1 ANTIODOR, ANTIMICROBIAL AND PRESERVATIVE COMPOSITIONS AND METHODS OF USING SAME Tristrata, Inc. (US) 1997-08-20 EP disclosed
US-5641475-A INCLUDES ARYL 2-ACETOXYETHANOIC ACID AS SYNERGIST OR AMPLIFIER TRISTRATA, INC. (US) 1997-06-24 US disclosed
WO-1996013247-A1 ANTIODOR, ANTIMICROBIAL AND PRESERVATIVE COMPOSITIONS AND METHODS OF USING SAME TRISTRATA, INC. (US) 1996-05-09 WO disclosed
US-4234733-A PHENOL, ALIPHATIC ESTER OR ETHER, CARBON MONOXIDE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1980-11-18 US disclosed
US-4234733-A PHENOL, ALIPHATIC ESTER OR ETHER, CARBON MONOXIDE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1980-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090772-A1 Oligosaccharide Aldonic Acids and Their Topical Use GLA, ALDOA, MAN2A1 ALDH1A1 206/4885CYP19A1 1123/4885SMN1; SMN2 1206/4885
US-20020028227-A1 Oligosaccharide aldonic acids and their topical use GLA, ALDOA, MAN2A1 ALDH1A1 206/4885CYP19A1 1123/4885SMN1; SMN2 1206/4885
US-20040180854-A1 Oligosaccharide aldonic acids and their topical use GLA, ALDOA, MAN2A1 ALDH1A1 206/4885CYP19A1 1123/4885SMN1; SMN2 1206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.